Malignant melanoma Antibody

Malignant melanoma Antibody

Primary malignant melanoma

ME204 TissueArray each 534 EUR
Description: Primary malignant melanoma, metastatic malignant melanoma and skin tissue array, incluing TNM /Stage, 68 cases/204 cores (core size 1.0mm),replacing ME208

Malignant melanoma tissue array

ME1005a TissueArray each 414 EUR
Description: Malignant melanoma tissue array, including TNM and clinical stage, 50cases/ 100 cores, replacing ME1005

Malignant melanoma tissue array

ME483a TissueArray each 270 EUR
Description: Malignant melanoma tissue array, including TNM and clinical stage, 48 cases/48 cores, replacing ME483

Malignant melanoma tissue array

ME804a TissueArray each 348 EUR
Description: Malignant melanoma tissue array, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replaced by ME804b

Malignant melanoma tissue array

ME804b TissueArray each 348 EUR
Description: Malignant melanoma tissue array, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing ME804a

Malignant melanoma tissue array

T386a TissueArray each 66 EUR
Description: Malignant melanoma tissue array, with normal skin tissue, including TNM and clinical stage, 6 cases/24 cores, replacing T386

Malignant melanoma tissue array

T388b TissueArray each 66 EUR
Description: Malignant melanoma tissue array, including TNm and clinical stage, 6 cases/24 cores, replacing T388a

Mucosa malignant melanoma tissue array

BCC38018 TissueArray each 270 EUR
Description: Mucosa malignant melanoma tissue array, 40 cases/80 cores

Metastatic malignant melanoma tissue array

BCC38218 TissueArray each 270 EUR
Description: Metastatic malignant melanoma tissue array, 50 cases/100 cores

Malignant melanoma test tissue array

T385b TissueArray each 66 EUR
Description: Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases/24 cores, replacing T385a

Malignant melanoma and metastatic malignant melanoma TMA with 6 matched cancer adjacent tissue samples

ME551 TissueArray each 270 EUR
Description: Malignant melanoma and metastatic malignant melanoma TMA with 6 matched cancer adjacent tissue samples, including TNM and clinical stage (reference AJCC th version), 49cases/55 cores (core size 1.5mm) Recent Year Collection

Malignant melanoma with skin tissue array

ME1002b TissueArray each 348 EUR
Description: Malignant melanoma with skin tissue array, including TNM and clinical satge, 50 cases/100 cores, replacing ME1002a

Malignant melanoma with skin tissue array

ME2082d TissueArray each 546 EUR
Description: Malignant melanoma with skin tissue array, including TNM and clinical stage, 188 cases/192 cores(1.0mm), replacing ME2082c

Malignant melanoma with skin tissue array

ME242c TissueArray each 108 EUR
Description: Malignant melanoma with skin tissue array, including TNM and clinical stage, 24 cases/24 cores, replacing ME242b

Malignant melanoma with skin tissue array

ME803b TissueArray each 306 EUR
Description: Malignant melanoma with skin tissue array, including TNM and clinical stage, 80 cases/80 cores (core size 1.5mm), replacing ME803a

Malignant melanoma and benign nevus tissue array

SK181 TissueArray each 174 EUR
Description: Malignant melanoma and benign nevus tissue array, including TNM and clinical stage, 18 cases/18 cores

Malignant melanoma with skin tissue test array

T383a TissueArray each 66 EUR
Description: Malignant melanoma with skin tissue test array, including TNM and clinical stage, 6 cases/24 cores, replacing T383

Paraffin Tissue Section - Human Skin Tumor: Malignant Melanoma

T2235218-3 Biochain 5 slides 308.4 EUR
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Malignant melanoma test tissue array with skin tissue

T382c TissueArray each 66 EUR
Description: Malignant melanoma test tissue array with skin tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T382b

Multiple sites malignant melanoma and normal skin tissue array

ME2081 TissueArray each 474 EUR
Description: Multiple sites malignant melanoma and normal skin tissue array, including TNM and clinical stage, 104 cases/208 cores (core size 1.5mm)

Human Malignant melanoma (single section per slide) (5 slides/pack)

HuCAT576 TissueArray 5 slides 180 EUR

Multiple malignant melanoma tissue array with adjacent normal skin tissue

ME241b TissueArray each 66 EUR
Description: Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases/24 cores, replacing ME241a

Skin malignant melanoma tissue array with adjacent skin tissue as control

ME811 TissueArray each 270 EUR
Description: Skin malignant melanoma tissue array with adjacent skin tissue as control, including TNM, clinical stage, 42 cases/ 81 cores

Skin malignant melanoma tissue array with adjacent normal or normal skin tissue as control

ME482a TissueArray each 270 EUR
Description: Skin malignant melanoma tissue array with adjacent normal or normal skin tissue as control, 48 cases/ 48 cores, replacing ME482

Penis Tissue Slide (Malignant)

12-204-10um ProSci 10 um 241.8 EUR

Penis Tissue Slide (Malignant)

12-204-4um ProSci 4 um 216.6 EUR

Malignant fibrohistiocytoma tissue array

SO802 TissueArray each 270 EUR
Description: Malignant fibrohistiocytoma tissue array, 80 cases/80 cores

Melanoma Antibody / PNL2

V3071-100UG NSJ Bioreagents 100 ug 499 EUR
Description: Anti-PNL2 is a novel melanoma marker monoclonal antibody, which has recently been introduced as an immunohistochemical reagent to stain melanocytes and tumors derived therefrom. The antigen recognized by PNL2 is different from Melan A and gp100. Its epitope is not destroyed by digestion with neuraminidase i.e. its epitope is not glycosylated. Anti-PNL2 may be most useful because of its high sensitivity for metastatic melanoma (87%), as opposed to 76% for anti-HMB45 and 82% for anti-MART-1. Anti-PNL2 labels intra-epidermal nevi while the dermal component of compound nevi are largely non-reactive with anti-PNL2. Antibodies against PNL2, MART-1 (Melan A) and HMB45 stain most clear cell sarcoma cells and a few cells in angiomyolipomas and lymphangioleiomyomatosis. Anti-PNL2 is a useful antibody for the identification of melanomas and clear cell sarcomas. Differential diagnosis is aided by the results from a panel of antibodies, including antibodies against HMB45, MART-1, tyrosinase, and MiTF.

Melanoma Antibody / PNL2

V3071-20UG NSJ Bioreagents 20 ug 219 EUR
Description: Anti-PNL2 is a novel melanoma marker monoclonal antibody, which has recently been introduced as an immunohistochemical reagent to stain melanocytes and tumors derived therefrom. The antigen recognized by PNL2 is different from Melan A and gp100. Its epitope is not destroyed by digestion with neuraminidase i.e. its epitope is not glycosylated. Anti-PNL2 may be most useful because of its high sensitivity for metastatic melanoma (87%), as opposed to 76% for anti-HMB45 and 82% for anti-MART-1. Anti-PNL2 labels intra-epidermal nevi while the dermal component of compound nevi are largely non-reactive with anti-PNL2. Antibodies against PNL2, MART-1 (Melan A) and HMB45 stain most clear cell sarcoma cells and a few cells in angiomyolipomas and lymphangioleiomyomatosis. Anti-PNL2 is a useful antibody for the identification of melanomas and clear cell sarcomas. Differential diagnosis is aided by the results from a panel of antibodies, including antibodies against HMB45, MART-1, tyrosinase, and MiTF.

Melanoma Antibody / PNL2

V3071IHC-7ML NSJ Bioreagents 7 ml 499 EUR
Description: Anti-PNL2 is a novel melanoma marker monoclonal antibody, which has recently been introduced as an immunohistochemical reagent to stain melanocytes and tumors derived therefrom. The antigen recognized by PNL2 is different from Melan A and gp100. Its epitope is not destroyed by digestion with neuraminidase i.e. its epitope is not glycosylated. Anti-PNL2 may be most useful because of its high sensitivity for metastatic melanoma (87%), as opposed to 76% for anti-HMB45 and 82% for anti-MART-1. Anti-PNL2 labels intra-epidermal nevi while the dermal component of compound nevi are largely non-reactive with anti-PNL2. Antibodies against PNL2, MART-1 (Melan A) and HMB45 stain most clear cell sarcoma cells and a few cells in angiomyolipomas and lymphangioleiomyomatosis. Anti-PNL2 is a useful antibody for the identification of melanomas and clear cell sarcomas. Differential diagnosis is aided by the results from a panel of antibodies, including antibodies against HMB45, MART-1, tyrosinase, and MiTF.

Melanoma Antibody / PNL2

V3071SAF-100UG NSJ Bioreagents 100 ug 499 EUR
Description: Anti-PNL2 is a novel melanoma marker monoclonal antibody, which has recently been introduced as an immunohistochemical reagent to stain melanocytes and tumors derived therefrom. The antigen recognized by PNL2 is different from Melan A and gp100. Its epitope is not destroyed by digestion with neuraminidase i.e. its epitope is not glycosylated. Anti-PNL2 may be most useful because of its high sensitivity for metastatic melanoma (87%), as opposed to 76% for anti-HMB45 and 82% for anti-MART-1. Anti-PNL2 labels intra-epidermal nevi while the dermal component of compound nevi are largely non-reactive with anti-PNL2. Antibodies against PNL2, MART-1 (Melan A) and HMB45 stain most clear cell sarcoma cells and a few cells in angiomyolipomas and lymphangioleiomyomatosis. Anti-PNL2 is a useful antibody for the identification of melanomas and clear cell sarcomas. Differential diagnosis is aided by the results from a panel of antibodies, including antibodies against HMB45, MART-1, tyrosinase, and MiTF.

Melanoma Tissue Slide (Skin- Melanoma)

12-801-10um ProSci 10 um 241.8 EUR

Melanoma Tissue Slide (Skin- Melanoma)

12-801-4um ProSci 4 um 216.6 EUR

Liver Tissue Slide (Malignant tumor)

10-220-10um ProSci 10 um 241.8 EUR

Liver Tissue Slide (Malignant tumor)

10-220-4um ProSci 4 um 216.6 EUR

Stomach Tissue Slide (Malignant Tumor)

10-807-10um ProSci 10 um 241.8 EUR

Stomach Tissue Slide (Malignant Tumor)

10-807-4um ProSci 4 um 216.6 EUR

Small Intestine Tissue Slide (Malignant)

11-814-10um ProSci 10 um 241.8 EUR

Small Intestine Tissue Slide (Malignant)

11-814-4um ProSci 4 um 216.6 EUR

Ovary Tissue Slide (Malignant Tumor)

11-206-10um ProSci 10 um 241.8 EUR

Ovary Tissue Slide (Malignant Tumor)

11-206-4um ProSci 4 um 216.6 EUR

Stomach Tissue Slide (Malignant Tumor)

RF10002-05-10um ProSci 10 um 241.8 EUR

Stomach Tissue Slide (Malignant Tumor)

RF10002-05-4um ProSci 4 um 216.6 EUR

Skin malignant tumor tissue array

BC21014 TissueArray each 270 EUR
Description: Skin malignant tumor tissue array, 78 cases/78 cores, replacing BC21011

Melanoma associated antigen antibody

10R-M160a Fitzgerald 1 mL 626.4 EUR
Description: Mouse monoclonal Melanoma associated antigen antibody

Melanoma Marker(PNL2) Antibody

BNC040894-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), CF405S conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC040894-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), CF405S conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC050894-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), CF405M conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC050894-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), CF405M conjugate, Concentration: 0.1mg/mL

Melanoma Inhibitory Activity Antibody

DF14235 Affbiotech 100ul 420 EUR

Melanoma Marker(PNL2) Antibody

BNCAP0894-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNCAP0894-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNCB0894-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), Biotin conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNCB0894-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), Biotin conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNCP0894-250 Biotium 250uL 459.6 EUR
Description: Primary antibody against Melanoma Marker(PNL2), PerCP conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNCR0894-250 Biotium 250uL 459.6 EUR
Description: Primary antibody against Melanoma Marker(PNL2), RPE conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC940894-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), CF594 conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC940894-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), CF594 conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNCA0894-250 Biotium 250uL 459.6 EUR
Description: Primary antibody against Melanoma Marker(PNL2), APC conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC810894-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), CF680R conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC810894-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), CF680R conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNUB0894-100 Biotium 100uL 250.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), Concentration: 0.2mg/mL

Melanoma Marker(PNL2) Antibody

BNUB0894-500 Biotium 500uL 549.6 EUR
Description: Primary antibody against Melanoma Marker(PNL2), Concentration: 0.2mg/mL

Melanoma Marker(PNL2) Antibody

BNCH0894-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNCH0894-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC880894-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), CF488A conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC880894-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), CF488A conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC680894-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), CF568 conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC680894-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), CF568 conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC470894-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), CF647 conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC470894-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), CF647 conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody

BNC400894-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against Melanoma Marker(PNL2), CF640R conjugate, Concentration: 0.1mg/mL